全文获取类型
收费全文 | 15641篇 |
免费 | 1105篇 |
国内免费 | 374篇 |
专业分类
耳鼻咽喉 | 76篇 |
儿科学 | 379篇 |
妇产科学 | 201篇 |
基础医学 | 561篇 |
口腔科学 | 90篇 |
临床医学 | 3140篇 |
内科学 | 3492篇 |
皮肤病学 | 96篇 |
神经病学 | 1221篇 |
特种医学 | 929篇 |
外科学 | 2569篇 |
综合类 | 2089篇 |
预防医学 | 412篇 |
眼科学 | 69篇 |
药学 | 1017篇 |
17篇 | |
中国医学 | 412篇 |
肿瘤学 | 350篇 |
出版年
2024年 | 11篇 |
2023年 | 232篇 |
2022年 | 431篇 |
2021年 | 581篇 |
2020年 | 691篇 |
2019年 | 538篇 |
2018年 | 526篇 |
2017年 | 568篇 |
2016年 | 539篇 |
2015年 | 575篇 |
2014年 | 1149篇 |
2013年 | 1158篇 |
2012年 | 962篇 |
2011年 | 1020篇 |
2010年 | 846篇 |
2009年 | 804篇 |
2008年 | 781篇 |
2007年 | 764篇 |
2006年 | 671篇 |
2005年 | 596篇 |
2004年 | 451篇 |
2003年 | 452篇 |
2002年 | 333篇 |
2001年 | 276篇 |
2000年 | 231篇 |
1999年 | 174篇 |
1998年 | 180篇 |
1997年 | 180篇 |
1996年 | 139篇 |
1995年 | 165篇 |
1994年 | 141篇 |
1993年 | 109篇 |
1992年 | 103篇 |
1991年 | 79篇 |
1990年 | 85篇 |
1989年 | 80篇 |
1988年 | 77篇 |
1987年 | 36篇 |
1986年 | 50篇 |
1985年 | 64篇 |
1984年 | 57篇 |
1983年 | 22篇 |
1982年 | 38篇 |
1981年 | 32篇 |
1980年 | 26篇 |
1979年 | 32篇 |
1978年 | 9篇 |
1977年 | 13篇 |
1976年 | 15篇 |
1972年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
1.
2.
3.
4.
5.
南星羽马靓李海红 《中国卫生质量管理》2022,(8):072-76
目的总结骨科围手术期患者静脉血栓栓塞症(VTE)物理预防的证据,提高护理人员VTE物理预防措施实施依从性。方法根据澳大利亚JBI循证卫生保健中心证据总结方法学,检索骨科围手术期患者VTE物理预防相关文献,根据纳入文献类型,由研究人员独立进行质量评价,并提取、汇总最佳证据。结果共纳入文献17篇,包含10篇指南、1篇证据总结、2篇专家共识、4篇系统评价。经过分析,总结出7类共30条骨科围手术期患者VTE物理预防最佳证据。结论最佳证据可为护士提供循证依据。但在应用时,还需评估具体临床情境,结合专业判断和患者意愿,针对性选择证据,以促进护理质量的持续改进。 相似文献
6.
《Saudi Pharmaceutical Journal》2022,30(4):398-406
IntroductionThe risk of mortality in patients with COVID-19 was found to be significantly higher in patients who experienced thromboembolic events. Thus, several guidelines recommend using prophylactic anticoagulants in all COVID-19 hospitalized patients. However, there is uncertainty about the appropriate dosing regimen and safety of anticoagulation in critically ill patients with COVID-19. Thus, this study aims to compare the effectiveness and safety of standard versus escalated dose pharmacological venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19.MethodsA two-center retrospective cohort study including critically ill patients aged ≥ 18-years with confirmed COVID-19 admitted to the intensive care unit (ICU) at two tertiary hospitals in Saudi Arabia from March 1st, 2020, until January 31st, 2021. Patients who received either Enoxaparin 40 mg daily or Unfractionated heparin 5000 Units three times daily were grouped under the “standard dose VTE prophylaxis and patients who received higher than the standard dose but not as treatment dose were grouped under ”escalated VTE prophylaxis dose“. The primary outcome was the occurance of thrombotic events, and the secondary outcomes were bleeding, mortality, and other ICU-related complications.ResultsA total of 758 patients were screened; 565 patients were included in the study. We matched 352 patients using propensity score matching (1:1). In patients who received escalated dose pharmacological VTE prophylaxis, any case of thrombosis and VTE were similar between the two groups (OR 1.22;95 %CI 0.52–2.86; P = 0.64 and OR 0.75; 95% CI 0.16–3.38; P = 0.70 respectively). However, the odds of minor bleeding was higher in patients who received escalated VTE prophylaxis dose (OR 3.39; 95% CI 1.08–10.61; P = 0.04). There was no difference in the 30-day mortality nor in-hospital mortality between the two groups (HR 1.17;95 %CI0.79–1.73; P = 0.43 and HR 1.08;95 %CI 0.76–1.53; P = 0.83, respectively).ConclusionEscalated-dose pharmacological VTE prophylaxis in critically ill patients with COVID-19 was not associated with thrombosis, or mortality benefits but led to an increased risk of minor bleeding. This study supports previous evidence regarding the optimal dosing VTE pharmacological prophylaxis regimen for critically ill patients with COVID-19. 相似文献
7.
《Vaccine》2022,40(44):6431-6444
This is a Brighton Collaboration case definition of thrombosis and thromboembolism to be used in the evaluation of adverse events following immunization, and for epidemiologic studies for the assessment of background incidence or hypothesis testing. The case definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of SARS-CoV-2 vaccines. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by selected expert reviewers prior to submission. 相似文献
8.
Gynecologic Malignancy-Associated Venous Thromboembolism and Predictive Tool at Thammasat University Hospital 下载免费PDF全文
Karit JayasakoonAwassada PunyashthiraBanthisa SomboonJunya PattaraarchachaiKomsun Suwannarurk 《Asian Pacific journal of cancer prevention》2022,23(6):2113-2118
Objectives: Aims were to investigate the prevalence and risk factors of venous thromboembolism (VTE) in gynecologic malignancy cases. Value of screening tool (Caprini) for prediction of VTE was also assessed. Study design: A retrospective study of gynecologic malignancy subjects who underwent major gynecological operation via exploratory laparotomy at Thammasat University Hospital, Pathum Thani, Thailand from January 2015 to December 2020. Participants were categorized into VTE and non-VTE groups. Caprini score, associated laboratory and clinical factors of both groups were evaluated. Results: A total of 392 subjects were recruited into the study. Prevalence of VTE was 7.4 (29/392) percent. VTE was diagnosed in subjects with endometrial, ovarian and cervical cancer at percentage of 7.8 (15/192), 7.9 (11/138) and 5.7 (3/53), respectively. Demographic characters of both groups were comparable. VTE group had significant more Caprini score, platelets count and platelet lymphocyte ratio (PLR) than non-VTE group. Modified Caprini score (2 multiply Caprini score plus 1 multiply PLR) was generated for better VTE prediction. Sensitivity and specificity of Caprini (≥5.5) and modified Caprini scores (≥22.8) were 72.4 vs 39.4, and 79.3 vs 52.1 percent, respectively. Conclusion: Prevalence of VTE among gynecologic malignancy cases was 7.4 percent. The modified Caprini score was an alternative VTE predictive tool. Cut-off point of modified Caprini score at equal or more than 22.8 was proposed. 相似文献
9.
《Journal of vascular and interventional radiology : JVIR》2022,33(12):1476-1484.e2
PurposeTo evaluate temporal trends, practice variation, and associated outcomes with the use of intravascular ultrasound (US) during deep venous stent placement among Medicare beneficiaries.Materials and MethodsAll lower extremity deep venous stent placement procedures performed between January 1, 2017, and December 31, 2019 among Medicare beneficiaries were included. Temporal trends in intravascular US use were stratified by procedural setting and physician specialty. The primary outcome was a composite of 12-month all-cause mortality, all-cause hospitalization, or repeat target vessel intervention. The secondary outcome was a composite of 12-month stent thrombosis, embolization, or restenosis.ResultsAmong the 20,984 deep venous interventions performed during the study period, 15,184 (72.4%) utilized intravascular US. Moderate growth in intravascular US use was observed during the study period in all clinical settings. There was a variation in the use of intravascular US among all operators (median, 77.3% of cases; interquartile range, 20.0%–99.2%). In weighted analyses, intravascular US use during deep venous stent placement was associated with a lower risk of both the primary (adjusted hazard ratio, 0.72; 95% confidence interval [CI], 0.69–0.76; P < .001) and secondary (adjusted hazard ratio, 0.32; 95% CI, 0.27–0.39; P < .001) composite end points.ConclusionsIntravascular US is frequently used during deep venous stent placement among Medicare beneficiaries, with further increase in use from 2017 to 2019. The utilization of intravascular US as part of a procedural strategy was associated with a lower cumulative incidence of adverse outcomes after the procedure, including venous stent thrombosis and embolization. 相似文献
10.